AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices.

RecruitingNAAges 18 Years - anyAllFH ORTHO
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of this observatory is to generate additional real life clinical data in accordance with local regulation (i.e. Post-Market Clinical Follow-up (PMCF) study, a study carried out following the European Conformity (CE) marking of a device and intended to answer specific questions relating to clinical safety or performance (i.e. residual risks) of a device when used in accordance with its approved labelling). The difficulty of such an observatory is to be able to collect data on the different versions of the devices, on the different possible combinations of implants of an arthroplasty. The observatory must also be able to cover devices used in surgery to repair osteoarticular trauma. The observatory will be based on the principle of a "dynamic" cohort during the inclusion period, i.e. with possible inclusions to replace the premature exits. Technical solutions will be imple

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Any patient undergoing or having undergone implantation of medical devices distributed by FH ORTHO Company for hip arthroplasty and traumatology, used in accordance with their approved Instruction For Use, in one of the centers participating in the Observatory. 2. Patient is at least 18 years of age. 3. Patient agreeing to participate after having been informed orally and in writing (with written consent if required locally). 4. In some countries, such as France, the patient will have to be socially insured to be included in the study. Exclusion Criteria: 1. An infection, or latent infection. 2. A mental or neuromuscular disorder that would create an unacceptable risk of prosthetic instability, failure of prosthetic fixation, or post-operative complications (except for the HIP\&GO Double mobility cemented cup and, if applicable, the associated stems and heads when assembled together). 3. Known Insufficient bone quality and/or bone stock. 4. Known allergy to any component of the material listed on the product label. 5. Metabolic diseases that could compromise bone regrowth. 6. Metabolic and/or vascular treatment or disease that may compromise bone healing or consolidation. 7. Drug dependency. 8. Uncooperative patient unable to follow recommendations. 9. Protected adult
๐Ÿ’Š

What it tests

  • Hip surgery with FH Ortho devices
๐Ÿ“

Where

5 sites
Clinique Pasteur
Guilherand-Granges, France
Centre Hospitalier Du Haut Bugey
Oyonnax, France
Polyclinique Reims-Courlancy
Reims, France
Clinique Mutualiste La Sagesse
Rennes, France
Clinique de l'Atlantique
Saint-Herblain, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy